Skip to Content
Merck
  • A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy.

A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy.

Pain (2019-08-01)
Aisylu S Gaifullina, Joanna Lazniewska, Elena V Gerasimova, Gulshat F Burkhanova, Yuriy Rzhepetskyy, Andriy Tomin, Paula Rivas-Ramirez, Junting Huang, Leos Cmarko, Gerald W Zamponi, Guzel F Sitdikova, Norbert Weiss
ABSTRACT

Homocysteinemia is a metabolic condition characterized by abnormally high level of homocysteine in the blood and is considered to be a risk factor for peripheral neuropathy. However, the cellular mechanisms underlying toxic effects of homocysteine on the processing of peripheral nociception have not yet been investigated comprehensively. Here, using a rodent model of experimental homocysteinemia, we report the causal association between homocysteine and the development of mechanical allodynia. Homocysteinemia-induced mechanical allodynia was reversed on pharmacological inhibition of T-type calcium channels. In addition, our in vitro studies indicate that homocysteine enhances recombinant T-type calcium currents by promoting the recycling of Cav3.2 channels back to the plasma membrane through a protein kinase C-dependent signaling pathway that requires the direct phosphorylation of Cav3.2 at specific loci. Altogether, these results reveal an unrecognized signaling pathway that modulates the expression of T-type calcium channels, and may potentially contribute to the development of peripheral neuropathy associated with homocysteinemia.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Homocysteine, ≥98.0% (NT)
Sigma-Aldrich
Phorbol 12-myristate 13-acetate, ≥99% (TLC), film or powder
Sigma-Aldrich
ML218, ≥98% (HPLC)
Sigma-Aldrich
Poly-L-lysine solution, 0.01%, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Mibefradil dihydrochloride hydrate, ≥98% (HPLC), powder